ALM223
/ Almirall, Simcere
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 10, 2024
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=84 | Recruiting | Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Trial completion date: Dec 2024 ➔ Jul 2025 | Trial primary completion date: Sep 2024 ➔ May 2025
Trial completion date • Trial primary completion date • CD4 • CD8
September 01, 2023
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=84 | Recruiting | Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1